Guo Guangchang, aged 56, is an Executive Director and Chairman of the Company and the founder of the Group. As of 31 December 2023, Mr. Guo was also a director of both Fosun Holdings and Fosun International Holdings (the direct and indirect controlling shareholders of the Company, respectively), and an honorary chairman of the Zhejiang Chamber of Commerce, Shanghai, and etc. Mr. Guo has been awarded the title of "China Democratic League Anti-COVID-19 Outstanding Individual", the "Anti-epidemic Action Award" at the 2020 Ram Charan Management Practice Awards issued by Harvard Business Review (Chinese edition), the "Outstanding Businessman of Listed Company Award" at the Top 100 Hong Kong Listed Companies Awards, co-organized by Tencent News and Finet Group Limited, the "Lifetime Achievement Award" at the 16th CNBC Asia Business Leaders Awards Ceremony, the “China’s Top 50 Most Influential Business Leaders in 2023” by Fortune China”, and etc. Mr. Guo received a bachelor’s degree in philosophy in 1989 and a master’s degree in business administration in 1999, both from Fudan University.

Wang Qunbin, aged 54, is an Executive Director and Co-Chairman of the Company, and the founder of the Group. Mr. Wang has been a non-executive director of Fosun Pharma (listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange) and Sinopharm (listed on the Hong Kong Stock Exchange). Mr. Wang has been awarded the "Asia Pacific Outstanding Entrepreneur Award" by Enterprise Asia and the "Asian Corporate Director Recognition Award" at the Asian Excellence Awards by Corporate Governance Asia, and etc., and has been named one of the "Top 50 Ranking of China’s Business Leaders" by Harvard Business Review. Mr. Wang received a bachelor’s degree in Genetic Engineering from Fudan University in 1991.

Chen Qiyu, aged 51, is an Executive Director and Co-CEO of the Company. Mr. Chen joined the Group in 1994 and as of 31 December 2023, he was also a non-executive director of Fosun Pharma (listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange) and Shanghai Henlius (listed on the Hong Kong Stock Exchange), a non-executive director and vice chairman of Sinopharm (listed on the Hong Kong Stock Exchange), a director of Gland Pharma (listed on the BSE Limited and National Stock Exchange of India Limited). Mr. Chen was a director of Dian Diagnostics Group Co., Ltd. (listed on the Shenzhen Stock Exchange ChiNext market) and Sanyuan Foods (listed on the Shanghai Stock Exchange), a non-executive director of BabyTree (listed on the Hong Kong Stock Exchange), and a co-chairman of New Frontier Health Corporation (delisted from the New York Stock Exchange in January 2022). As of 31 December 2023, Mr. Chen was the chairman of China Medical Pharmaceutical Material Association, a vice chairman of China Pharmaceutical Innovation and Research Development Association, the honorary chairman and chief supervisor of Shanghai Biopharmaceutics Industry Association, and a member of the 14th Shanghai Standing Committee of the Chinese People’s Political Consultative Conference, and etc. Mr. Chen has been awarded "Asia’s Best CEO" by Corporate Governance Asia, and etc. Mr. Chen received a bachelor’s degree in genetics from Fudan University in 1993 and an EMBA degree from China Europe International Business School in 2005.

Xu Xiaoliang, aged 50, is an Executive Director and Co-CEO of Fosun International. Mr. Xu joined the Group in 1998. As of 31 December 2023, Mr. Xu was a non-executive director of Fosun Pharma (listed on the Hong Kong Stock Exchange and Shanghai Stock Exchange), an executive director and chairman of Fosun Tourism Group (listed on the Hong Kong Stock Exchange), a director of Yuyuan (listed on the Shanghai Stock Exchange), Shanghai Foyo Culture & Entertainment Co., Ltd. (delisted from the National Equities Exchange and Quotations in April 2021) and various companies within the Group. Mr. Xu was a non-independent director of Hainan Mining (listed on the Shanghai Stock Exchange), a non-executive director and vice chairman of Zhaojin Mining Industry Company Limited (listed on the Hong Kong Stock Exchange), and a director of Shanghai Resource Property Consulting Co., Ltd. (delisted from the National Equities Exchange and Quotations in December2020). As of 31 December 2023, Mr. Xu was a deputy to the 16th Shanghai Municipal People’s Congress and the chairman of Shanghai International Fashion Federation. Mr. Xu has been awarded “Asia’s Best CEO” by Corporate Governance Asia, the “Shanghai May Forth Youth Medal” and “Shanghai Top Ten Youth Businessmen”, and etc. Mr. Xu received a master’s degree in business administration from the East China Normal University in 2002 and received an EMBA degree from Fudan University in 2019.

Gong Ping, aged 48, is an Executive Director, Executive President and CFO of the Company. Mr. Gong joined the Group in 2011 and as of 31 December 2023, he was also a director of Yuyuan (listed on the Shanghai Stock Exchange) and various companies within the Group. He has been a senior assistant to president of the Group, the general manager of Corporate Development Department and the CEO of Fosun Hive, the chairman of PAREF (listed on the Euronext Paris), a non-executive director of Shanghai Zendai Property Limited (listed on the Hong Kong Stock Exchange) and Fosun Pharma (listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange), and a director of Shanghai Bailian Group Co., Ltd. (listed on the Shanghai Stock Exchange) and Resource Property (delisted from the National Equities Exchange and Quotations in December 2020). Prior to joining the Group, Mr. Gong worked at the Pudong branch and the headquarters of Bank of Shanghai as well as the PRC headquarters of Standard Chartered Bank. Mr. Gong also served as a global strategist at the headquarters of Samsung Group in Korea, carrying out special assignments across various sectors including financial services, technology and real estate worldwide. As of 31 December 2023, Mr. Gong was a council member of Shanghai Association for Youth Entrepreneurship and Employment. Mr. Gong received a bachelor’s degree in international finance from Fudan University in 1998, and obtained a master’s degree in finance from Fudan University in 2005. Mr. Gong also received a master’s degree in business administration from International Institute for Management Development (IMD) in Lausanne, Switzerland in 2008. 

Huang Zhen, aged 52, is an Executive Director, Executive President and CGO of the Company. Mr. Huang joined the Group in 2017 and as of 31 December 2023, he was also the chairman of Yuyuan (listed on the Shanghai Stock Exchange) and Lanvin Group (listed on the New York Stock Exchange), and a director of Shede Spirits (listed on the Shanghai Stock Exchange), Resource Property (delisted from the National Equities Exchange and Quotations in December 2020), Shanghai Bailian (listed on the Shanghai Stock Exchange) and Sanyuan Foods (listed on the Shanghai Stock Exchange) and Fosun Tourism Group (listed on the Hong Kong Stock Exchange) and various companies within the Group. Mr. Huang has been a non-executive director of Zhaojin Mining Industry Company Limited (listed on the Hong Kong Stock Exchange) and a director of Jinhui Liquor Company Limited (listed on the Shanghai Stock Exchange). Before joining the Group, Mr. Huang was the deputy general manager of Shanghai Jahwa United Co., Ltd., and the general manager of Shanghai Herborist Cosmetics Co., Ltd., and etc. As of 31 December 2023, Mr. Huang was a member of the 14th Shanghai Standing Committee of the Chinese People’s Political Consultative Conference and the 3rd Shanghai Huangpu District Standing Committee of the Chinese People’s Political Consultative Conference, the chairman of Shanghai Huangpu District Federation of Industry and Commerce, the president of Shanghai Huangpu District Chamber of Commerce, the vice chairman of China Gold Association and Gems & Jewelry Trade Association of China, and etc. Mr. Huang has been awarded "Top Ten Economic Figures in China’s Circulation Industry", "National Outstanding Commercial Entrepreneur", and etc. Mr. Huang received a bachelor’s degree in economics from Shanghai University of Finance and Economics in 1994 and an MBA degree from Webster University (USA) in 1998.

Pan Donghui, aged 54, is currently an Executive Director, Executive President and CHO of the Company. Mr. Pan was appointed as an executive director of the Company in March 2023. Mr. Pan joined the Group in 1994 and as of 31 December 2023, Mr. Pan was a non-executive director of Fosun Pharma (listed on the Shanghai Stock Exchange and the Hong Kong Stock Exchange) and Fosun Tourism Group (listed on the Hong Kong Stock Exchange) and a director of Shanghai Foyo Culture & Entertainment Co., Ltd. (delisted from the National Equities Exchange and Quotations in April 2021). Mr. Pan has also served as a director of Shanghai Ganglian E-Commerce Holdings Co., Ltd. (listed on the Shenzhen Stock Exchange). Mr. Pan obtained a bachelor’s degree in engineering from Shanghai Jiaotong University in China in 1991, and a master’s degree in business administration from the University of Southern California in the United States in 2009.

Li Shupei, aged 42, has been a Non-Executive Director of the Company since November 2022. As of 31 December 2023, Dr. Li was also the deputy head of the equity investment center and the head of research department of the equity center, and a non-executive director of Ronshine China Holdings Limited (listed on the Hong Kong Stock Exchange). Dr. Li has joined China Everwin Asset Management Co., Ltd. since 2018. From 2015 to 2018, Dr. Li served as a macro strategist and non-bank financial analyst and first-level researcher at the securities investment department of China Life Asset Management Company Limited. From 2010 to 2015, Dr. Li served as a macro analyst, strategist and vice president at the research and development department of CSC Financial Co., Ltd. (listed on the Hong Kong Stock Exchange). Dr. Li obtained a bachelor’s degree in management from Zhengzhou University in 2005, a master’s degree in economics in 2007 and a doctorate degree in economics in 2010 from Nankai University, respectively.

Li Fuhua, aged 53, has been the Non-Executive Director of the Company since February 2023. As of 31 December 2023, Mr. Li was also the financial director, the head of finance and the general manager of the planning and finance department of AEON Life Insurance Co., Ltd. (“AEON Life Insurance”), the head of finance of AEON Insurance Asset Management Co., Ltd., a director of Shanghai Zhuli Investment Co., Ltd. (a subsidiary of the Company) and an executive director of Wangjin Holdings (Dalian) Co., Ltd. From 1993 to 1997, Mr. Li served as the accounting supervisor of the financial department of Jinan silk factory of Shandong Provincial Silk Corporation. From 1997 to 2000, he served as the financial supervisor and financial manager of the financial department of China Ping An Life Insurance Co., Ltd. (“Ping An Life Insurance”) Jinan Branch. From 2000 to 2002, he served as the director of the financial department and the project manager of financial enterprise resource planning (ERP) of Ping An Life Insurance. From 2002 to 2004, he was the director of the financial management office of the financial planning department of Ping An Insurance (Group) Company of China, Ltd. (listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange). From 2004 to 2008, he served as the assistant general manager of the financial department of Taikang Life Insurance Co., Ltd. (“Taikang Life Insurance”). From 2009 to 2013, he served as the deputy general manager of the financial department of Taikang Life Insurance. From 2013 to 2017, he served as the general manager of the accounting department of AEON Life Insurance. Mr. Li graduated from Shandong College of Finance (currently known as Shandong University of Finance and Economics) with a bachelor’s degree in accountancy in 1998. Mr. Li holds certificates of qualification of Senior International Finance Manager and International Certified Management Accountant.

Zhang Shengman, aged 66, has been an Independent Non-Executive Director of the Company since December 2006. As of 31 December 2023, Mr. Zhang was also a non-executive director of Seazen Group Limited (listed on the Hong Kong Stock Exchange),  an independent non-executive director of China Lilang Limited (listed on the Hong Kong Stock Exchange) and Green Economy Development Limited (listed on the Hong Kong Stock Exchange). Mr. Zhang worked in the PRC Ministry of Finance as a deputy director and vice secretary from 1987 to 1992. From 1993 to 2005, Mr. Zhang served as an executive director for China, vice president and chief secretary, senior vice director, managing director and chairman of the operations committee, the sanctions committee and the corporate committee on fraud and corruption policy of the World Bank. Mr. Zhang joined Citigroup Inc. (listed on the New York Stock Exchange) in February 2006, and up to May 2016 once served as the chairman of the Public Sector Group, chairman and president of the Asia Pacific region of the Public Sector Group. Mr. Zhang received a bachelor’s degree in English literature from Fudan University in 1978 and a master’s degree in public administration from University of the District of Columbia in1986. Mr. Zhang completed the Harvard Advanced Management Program in 1997.

Zhang Huaqiao, aged 60, has been an Independent Non-Executive Director of the Company since March 2012. As of 31 December 2023, Mr. Zhang was an independent non-executive director of Zhong An Group Limited, Logan Group Company Limited, Luye Pharma Group Ltd., Radiance Holdings (Group) Company Limited and Haitong International Securities Group Limited, all of which are listed on the Hong Kong Stock Exchange. From July 1986 to January 1989, Mr. Zhang was employed at the People’s Bank of China and from June 1999 to April 2006, Mr. Zhang worked at the Equities Department of UBS AG, Hong Kong Branch at which he first served as the head of China research and later became a co-head of China research. Mr. Zhang was the chief operating officer from March 2006 to September 2008 and an executive director from May 2006 to September 2008 of Shenzhen Investment Limited (listed on the Hong Kong Stock). From September 2008 to June 2011, he was the deputy head of China Investment Banking at UBS Securities Asia Limited. Mr. Zhang has also been a non-executive director of Boer Power Holdings Limited (listed on the Hong Kong Stock Exchange), an independent non-executive director of China Huirong Financial Holdings Limited (listed on the Hong Kong Stock Exchange) and China Rapid Finance Limited (listed on the New York Stock Exchange), and a non-executive director, an executive director and the chairman of China Smartpay Group Holdings Limited (listed on the Hong Kong Stock Exchange). Mr. Zhang graduated from the Graduate School of the People’s Bank of China with a master’s degree in economics in 1986 and from the Australian National University with a master’s degree in economics in 1991.

David T. Zhang, aged 61, has been an Independent Non-Executive Director of the Company since June 2012. Mr. Zhang has also been a senior corporate partner in the Hong Kong office of Kirkland & Ellis International LLP, a leading international law firm. Admitted to the practice of law in New York, the United States and based in Hong Kong, Mr. Zhang specializes in securities offerings and M&A transactions. He has extensive experience representing Chinese issuers and leading investment banks in the United States in initial public offerings, Hong Kong initial public offerings and other Rule 144A and Regulation S offerings of equity, debt and convertible securities. Mr. Zhang has represented a number of leading private equity funds, multinational corporations and sovereign wealth funds in connection with their investments and M&A transactions in the Greater China region and Southeast Asia. In addition, Mr. Zhang has successfully guided China-based companies listed in the Unites States and Hong Kong through complex mission-critical moments, counselling leaders and boards of directors on high stakes matters at the intersection of litigation, regulatory enforcement, reputation and public policy. Mr. Zhang has been rated as a top capital markets attorney by Chambers Global, Legal 500 Asia Pacific, IFLR1000 and Chambers Asia Pacific. Prior to joining Kirkland & Ellis International LLP in August 2011, Mr. Zhang has been a partner of Latham & Watkins LLP, a leading international law firm for eight years. Mr. Zhang graduated from Beijing Foreign Studies University in 1981 and received his J.D. degree from Tulane University Law School in 1991.

Lee Kai-Fu, aged 62, has been an Independent Non-Executive Director of the Company since March 2017. As of 31 December 2023, Dr. Lee was the chairman of Sinovation Ventures (Beijing) Enterprise Management Co., Ltd., a co-founder and the managing partner of Sinovation Ventures Development Funds, the chairman and CEO of Innovation Works Limited, a non-executive director of Meitu, Inc. (listed on the Hong Kong Stock Exchange) and the chairman and non-executive director of Qingdao Ainovation Technology Group Co., Ltd. (listed on the Hong Kong Stock Exchange). Dr. Lee has also been a director of various companies in the internet, artificial intelligence and other industries. From 1988 to 1990, Dr. Lee worked at Carnegie Mellon University, where he served as an assistant professor. During July 1990 and April 1996, Dr. Lee worked at Apple Inc. (listed on NASDAQ) and serving as a vice-president from December 1995. From July 1998 to July 2005, Dr. Lee was the vice president of Microsoft Corporation (listed on NASDAQ). From July 2005 to September 2009, Dr. Lee was the president of Google China of Google Inc. (listed on NASDAQ), and was responsible for launching the Google China R&D Centre. Dr. Lee has also been an independent director of LightInTheBox Holding Co., Ltd. (listed on the New York Stock Exchange), an independent non-executive director of Shangri-La Asia Limited (listed on the Hong Kong Stock Exchange) and Hon Hai Precision Industry Co., Ltd. (listed on the Taiwan Stock Exchange). Dr. Lee received a Bachelor of Arts degree and a PhD degree in Computer Science from Columbia University in 1983 and Carnegie Mellon University in 1988, respectively, and received honorary doctorate degrees from City University of Hong Kong and Carnegie Mellon University in 2010 and 2015, respectively.

Tsang King Suen Katherine, aged 66, has been an Independent Non-Executive Director of the Company since December 2020. Ms. Tsang is the founder of Max Giant Capital. As of 31 December 2023, Ms. Tsang was also the executive director and CEO of HK Acquisition Corporation (listed on the Hong Kong Stock Exchange), an independent non-executive director of Budweiser Brewing Company APAC Limited (listed on the Hong Kong Stock Exchange), Fidelity Emerging Markets Limited (listed on the London Stock Exchange) and China CITIC Bank International Limited. Ms. Tsang was an independent non-executive director of Baoshan Iron & Steel Co., Ltd. (listed on the Shanghai Stock Exchange) from May 2006 to April 2012, the chairperson of Greater China of Standard Chartered Bank from August 2009 to August 2014, and an independent non-executive director of Gap Inc. (listed on the New York Stock Exchange) from August 2010 to May 2018. As of 31 December 2023, Ms. Tsang was a member of the Advisory Council for China of the City of London, an honorary board member of Shanghai Jiao Tong University and the member of Finance and Investment Committee of The Boys’ and Girls’ Clubs Association of Hong Kong. Ms. Tsang was a member of the World Economic Forum’s Global Agenda Council on China from 2009 to 2012 and a member of Sotheby’s Asia Advisory Board from November 2011 to October 2014. Ms. Tsang graduated from University of Alberta, Canada with a bachelor’s degree in commerce in 1978.